city New Delhi India city Hyderabad covid-19 vaccine Department city New Delhi India city Hyderabad

Biological E. gets DCGI nod for covid vaccine trials on adults, children

Reading now: 257
www.livemint.com

NEW DELHI : Hyderabad-based pharmaceutical firm Biological E. has received the Drugs Controller General of India's (DCGI) approval to conduct two clinical trials-- one in adults and the other in children and adolescents --for its covid-19 vaccine candidate Corbevax, the Department of Biotechnology (DBT) said on Friday. “Biological E.

has received Drugs Controller General of India (DCGI) approval for conducting Phase III Comparator Safety & Immunogenicity trial in adults after Subject Expert Committee’s (SEC) review of Phase I and II clinical trials data," the Ministry of Science & Technology said.

The company also received approval on 1 September to initiate aPhase II/III study to evaluate "safety, reactogenicity, tolerability and

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA